Wei et al. reported that a 17% reduction in the risk of stroke with GLP1-Ra (vs. placebo) (RR = 0.83, 95% CI (0.73, 0.95), p = 0.005) was at the cost of ischemic stroke (RR = 0.83, 95% CI (0.73, 0.95), p = 0.008) reduction, with no effect on hemorrhagic stroke (RR = 0.83, 95% CI (0.57, 1.20), p = 0.31) [41]. The gene discussed is GLP1R; the disease is stroke disorder.